A new personalised vaccine given in combination with an immunotherapy drug has stopped skin cancer returning in patients during a trial.
This could be a major moment in cancer treatment. But how did it work – and what could it mean for future patients?
In this video…
01:11 What is melanoma and who took part in this trial?
02:01 Trial results
03:26 Personalised vaccines
04:21 How are personalised vaccines made?
05:00 Production challenges of personalised vaccines
05:57 Moderna and Merck share surge
06:29 When could patients get this vaccine?
Subscribe to our channel here: https://bbc.in/bbcnews
For the latest news download the BBC News app or visit BBC.com/news
#BBCNews
